{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T17:27:41Z","timestamp":1780853261677,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.semarthrit.2008.11.003","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T09:25:43Z","timestamp":1232097943000},"page":"313-319","source":"Crossref","is-referenced-by-count":106,"title":["Sarcoidosis Appearing During Anti-Tumor Necrosis Factor \u03b1 Therapy: A New \u201cClass Effect\u201d Paradoxical Phenomenon. Two Case Reports and Literature Review"],"prefix":"10.1016","volume":"39","author":[{"given":"Alfonso","family":"Massara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Cavazzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"La Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2008.11.003_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.semarthrit.2007.05.004","article-title":"The enigmatic development of psoriasis and psoriasiform lesions during anti-TNF therapy: a review","volume":"37","author":"Grinblat","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib2","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib3","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1378\/chest.127.3.1064","article-title":"Treatment of sarcoidosis with infliximab","volume":"127","author":"Doty","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ard.2004.028498","article-title":"The utility of tumour necrosis factor blockade in orphan diseases","volume":"63","author":"Keystone","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10067-005-0037-9","article-title":"Treatment of therapy-resistant sarcoidosis with adalimumab","volume":"25","author":"Callejas-Rubio","year":"2006","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib7","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/art.21716","article-title":"Pulmonary fibrosis in a patient with rheumatoid arthritis treated with adalimumab","volume":"55","author":"Schoe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1080\/03009740410005836","article-title":"Severe interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Chatterjee","year":"2004","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib9","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/ard.2005.044453","article-title":"Fatal exacerbation of fibrosing alveolitis associated with systemic sclerosis in a patient treated with adalimumab","volume":"65","author":"Allanore","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib10","first-page":"1151","article-title":"Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis","volume":"34","author":"Hagiwara","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib11","first-page":"1189","article-title":"Interstitial pneumonitis associated with infliximab therapy","volume":"33","author":"Villeneuve","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib12","first-page":"622","article-title":"Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis","volume":"33","author":"Ost\u00f6r","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2796.2003.01074.x","article-title":"The cytokine network in sarcoidosis and its clinical relevance","volume":"253","author":"Ziegenhagen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.22238","article-title":"Development of sarcoidosis during etanercept therapy","volume":"55","author":"Gonz\u00e1lez-L\u00f3pez","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib15","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s10067-007-0594-1","article-title":"Development of sarcoidosis in etanercept-treated rheumatoid arthritis patients","volume":"26","author":"Verschueren","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib16","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/art.22351","article-title":"Pulmonary sarcoidosis developing during infliximab therapy","volume":"55","author":"O'Shea","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib17","first-page":"99","article-title":"Pulmonary sarcoidosis in a patient with ankylosing spondylitis treated with infliximab","volume":"25","author":"Almod\u00f3var","year":"2007","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1592\/phco.27.10.1446","article-title":"Pulmonary sarcoidosis associated with etanercept therapy","volume":"27","author":"Farah","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib19","first-page":"648","article-title":"Sarcoid-like granulomatous disease following etanercept treatment for RA","volume":"34","author":"Kudrin","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib20","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2007.078840","article-title":"Relapse of sarcoidosis upon treatment with etanercept","volume":"67","author":"Louie","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib21","first-page":"2313","article-title":"Neurosarcoidosis in a patient with rheumatoid arthritis during treatment with infliximab","volume":"34","author":"Sturfelt","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib22","first-page":"645","article-title":"Sarcoid-related uveitis occurring during etanercept therapy","volume":"21","author":"Hashkes","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib23","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.2169\/internalmedicine.47.0602","article-title":"Development of sarcoidosis during etanercept therapy","volume":"47","author":"Ishiguro","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib24","first-page":"471","article-title":"Sarcoidosis occurring during anti-TNF-\u03b1 treatment for inflammatory rheumatic diseases: report of two cases","volume":"26","author":"Toussirot","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib25","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.10535","article-title":"Accelerated nodulosis and vasculitis following etanercept therapy for rheumatoid arthritis","volume":"47","author":"Cunnane","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib26","first-page":"1590","article-title":"Etanercept-related extensive pulmonary nodulosis in a patient with rheumatoid arthritis","volume":"34","author":"Van Ede","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.10096","article-title":"Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept","volume":"46","author":"Kekow","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib28","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/art.11154","article-title":"Pulmonary rheumatoid nodules in an etanercept-treated patient","volume":"48","author":"H\u00fcbscher","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib29","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/rheumatology\/ken102","article-title":"Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis","volume":"47","author":"Watson","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.rhu.0000147054.26777.43","article-title":"Accelerated cutaneous nodulosis during infliximab therapy in a patient with rheumatoid arthritis","volume":"10","author":"Mackley","year":"2004","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib31","first-page":"1467","article-title":"Giant cell arteritis in a patient taking etanercept and methotrexate","volume":"31","author":"Seton","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib32","first-page":"349","article-title":"Granulomatous hepatitis associated with etanercept therapy","volume":"35","author":"Farah","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib33","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor alpha inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2006.01949.x","article-title":"Granulomatous tattoo reaction in a patient treated with etanercept","volume":"21","author":"Bachmeyer","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib35","first-page":"1222","article-title":"Cutaneous granulomas during infliximab therapy for spondyloarthropathy","volume":"35","author":"Dubosc","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib36","first-page":"532","article-title":"New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept","volume":"35","author":"Song","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib37","article-title":"Adalimumab-induced noncaseating granuloma in the bone marrow of a patient being treated for rheumatoid arthritis","author":"Metyas","year":"2008","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib38","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib39","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.21336","article-title":"Granulomatous lung disease occurring during etanercept treatment","volume":"53","author":"Phillips","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib40","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1378\/chest.122.5.1858","article-title":"Lung injury linked to etanercept therapy","volume":"122","author":"Peno-Green","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/thorax.58.3.278","article-title":"Pulmonary granulomas after tumour necrosis factor alpha antagonist therapy","volume":"58","author":"Vavricka","year":"2003","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/modpathol.3800333","article-title":"Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy","volume":"18","author":"Yousem","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib43","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.mpmed.2008.03.005","article-title":"Pulmonary sarcoidosis","volume":"36","author":"FitzGerald","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib44","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7326\/0003-4819-127-5-199709010-00003","article-title":"Risk factors for methotrexate-induced lung injury in patients with rheumatoid arthritis. A multicenter, case-control study. Methotrexate-Lung Study Group","volume":"127","author":"Alarc\u00f3n","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1034\/j.1399-3003.2000.15b25.x","article-title":"Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients","volume":"15","author":"Imokawa","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib46","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/art.1780401016","article-title":"Clinical, laboratory, radiographic, and histopathologic features of methotrexate-associated lung injury in patients with rheumatoid arthritis: a multicenter study with literature review","volume":"40","author":"Kremer","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"5 Suppl 1","key":"10.1016\/j.semarthrit.2008.11.003_bib47","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.semarthrit.2005.01.009","article-title":"Tumor necrosis factor and granuloma biology: explaining the differential infection risk of etanercept and infliximab","volume":"34","author":"Wallis","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib48","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib49","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/gast.2001.28702","article-title":"Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway","volume":"121","author":"L\u00fcgering","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib50","first-page":"35","article-title":"Why does tumor necrosis factor targeted therapy reactivate tuberculosis?","volume":"74","author":"Ehlers","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib51","first-page":"40","article-title":"Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment","volume":"74","author":"Dinarello","year":"2005","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib52","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/art.23447","article-title":"Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor alpha-expressing cells: comparison among infliximab, etanercept, and adalimumab","volume":"58","author":"Mitoma","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.20764","article-title":"Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report","volume":"52","author":"Catrina","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.semarthrit.2006.02.001","article-title":"Tumor necrosis factor antagonists: different kinetics and\/or mechanisms of action may explain differences in the risk for developing granulomatous infection","volume":"36","author":"Furst","year":"2006","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.62.6.561","article-title":"Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis during treatment with etanercept","volume":"62","author":"Zou","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib56","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/art.10847","article-title":"Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab","volume":"48","author":"Zou","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib57","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1002\/art.21233","article-title":"Psoriasis induced by anti-tumor necrosis factor therapy: a paradoxical adverse reaction","volume":"52","author":"Sfikakis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib58","first-page":"434","article-title":"New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect?","volume":"34","author":"Roux","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib59","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.174.6.1461","article-title":"The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1","volume":"174","author":"Berg","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.semarthrit.2008.11.003_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/ard.60.2.133","article-title":"Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors","volume":"60","author":"Berg","year":"2001","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208002023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017208002023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T04:22:58Z","timestamp":1709958178000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017208002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0049017208002023"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2008.11.003","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}